Hawai'i Innovation Laboratory, Inc.

Honolulu, HI · Medtech · Private

wearable anti-pathogenic respirator with integrated photocatalytic microreactor for pathogen neutralization

hawaiiinnovationlab.com →
Grants
$419K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Agriculture · In Vitro Fertilization (ivf) And Embryo Transfer (et) Are Well-established Assisted Reproductive Techniques In The Cattle Industry. The Protocols Have Matured Through Decades Of Improvements, Yet The Conception Rate Following Ivf/et In Cattle Is Around 35-45%. The Major Limiting Factors For Et And Ivf Are Labor-intensive Protocols, Dependence On Practitioner Expertise, Poor Super Ovulatory Response, And Inaccurate Embryo Assessment. This Research Effort Aims To Solve Two Of The Significant Chall$175,000
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Anti-viral Active Air-Purifying Respirator with Photocatalytic Microreactor to Prevent Airborne Diseases$243,500
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1826FLOWPOINT MEDICAL INC——
1827LF PRINTECH LLC——
1828APPLIED NANOSTRUCTURES, INC.——
1829Hawai'i Innovation Laboratory, Inc.——
1830PHARMACOUSTICS TECHNOLOGIES LLC——
1831VERALASE, LLC——
1832MR-LINK, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.